Development of individual plasmonic nanosensors for clinical diagnosis

Phuoc Long Truong, Sang Jun Sim

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Accurate detection of panels of protein biomarkers in serum, saliva, or tissue plays an important role in early detection of diseases. Recently, our lab has developed the localized surface plasmon resonance (LSPR)-based immunosensors with highly promising analytical approach for qualification and quantification of biochemical substances in various applications. The LSPR of noble nanoparticles shifts upon refractive index changes of the dielectric environment surrounding the nanoparticles, subsequently causing a peak shift of the LSPR; it is also very sensitive to the binding events near the nanoparticle surface. Therefore, individual nanoparticles are sufficiently sensitive to detect the molecular interactions on the nanoparticle surface induced by biological molecules at ultralow concentrations. Furthermore, LSPR λmax shifts induced by adsorbates on the nanoparticle surface are completely linear with the number of bound molecules. Owing to this reason, each nanoparticle can be used as an independent sensor. By functionalizing the nanoparticle surface with the appropriate receptors, individual nanoparticle sensors can be used as diagnostic tools for a variety of diseases. Herein, we introduce the resonant Rayleigh scattering properties of single Au nanoparticles and the use of single Au nanoparticles as the plasmonic transducers to detect the binding of protein biomarkers to specific receptors conjugated gold nanoparticles. The principle of detection based on the resonant Rayleigh scattering response of single Au nanoparticles and the LSPR λmax shift of resonant Rayleigh scattering spectrum. This approach holds great promise as a simple, label-free, ultrasensitive method for detection of protein biomarkers in clinical diagnostics.

Original languageEnglish
Title of host publicationIFMBE Proceedings
PublisherSpringer Verlag
Pages1-6
Number of pages6
Volume46
ISBN (Print)9783319117751
DOIs
Publication statusPublished - 2015
Event5th International Conference on the Development of Biomedical Engineering, 2014 - Ho Chi Minh City, Viet Nam
Duration: 2014 Jun 162014 Jun 18

Other

Other5th International Conference on the Development of Biomedical Engineering, 2014
CountryViet Nam
CityHo Chi Minh City
Period14/6/1614/6/18

Fingerprint

Nanosensors
Nanoparticles
Surface plasmon resonance
Rayleigh scattering
Biomarkers
Proteins
Immunosensors
Molecules
Molecular interactions
Sensors
Adsorbates
Gold

Keywords

  • Au nanoparticles (AuNPs)
  • Localized surface plasmon resonance (LSPR)
  • Plasmonic nanosensors
  • Rayleigh light scattering (RLS)

ASJC Scopus subject areas

  • Biomedical Engineering
  • Bioengineering

Cite this

Development of individual plasmonic nanosensors for clinical diagnosis. / Truong, Phuoc Long; Sim, Sang Jun.

IFMBE Proceedings. Vol. 46 Springer Verlag, 2015. p. 1-6.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Truong, PL & Sim, SJ 2015, Development of individual plasmonic nanosensors for clinical diagnosis. in IFMBE Proceedings. vol. 46, Springer Verlag, pp. 1-6, 5th International Conference on the Development of Biomedical Engineering, 2014, Ho Chi Minh City, Viet Nam, 14/6/16. https://doi.org/10.1007/978-3-319-11776-8_1
Truong, Phuoc Long ; Sim, Sang Jun. / Development of individual plasmonic nanosensors for clinical diagnosis. IFMBE Proceedings. Vol. 46 Springer Verlag, 2015. pp. 1-6
@inproceedings{0f19b8101eca4ad8b6ed3578c3f7597f,
title = "Development of individual plasmonic nanosensors for clinical diagnosis",
abstract = "Accurate detection of panels of protein biomarkers in serum, saliva, or tissue plays an important role in early detection of diseases. Recently, our lab has developed the localized surface plasmon resonance (LSPR)-based immunosensors with highly promising analytical approach for qualification and quantification of biochemical substances in various applications. The LSPR of noble nanoparticles shifts upon refractive index changes of the dielectric environment surrounding the nanoparticles, subsequently causing a peak shift of the LSPR; it is also very sensitive to the binding events near the nanoparticle surface. Therefore, individual nanoparticles are sufficiently sensitive to detect the molecular interactions on the nanoparticle surface induced by biological molecules at ultralow concentrations. Furthermore, LSPR λmax shifts induced by adsorbates on the nanoparticle surface are completely linear with the number of bound molecules. Owing to this reason, each nanoparticle can be used as an independent sensor. By functionalizing the nanoparticle surface with the appropriate receptors, individual nanoparticle sensors can be used as diagnostic tools for a variety of diseases. Herein, we introduce the resonant Rayleigh scattering properties of single Au nanoparticles and the use of single Au nanoparticles as the plasmonic transducers to detect the binding of protein biomarkers to specific receptors conjugated gold nanoparticles. The principle of detection based on the resonant Rayleigh scattering response of single Au nanoparticles and the LSPR λmax shift of resonant Rayleigh scattering spectrum. This approach holds great promise as a simple, label-free, ultrasensitive method for detection of protein biomarkers in clinical diagnostics.",
keywords = "Au nanoparticles (AuNPs), Localized surface plasmon resonance (LSPR), Plasmonic nanosensors, Rayleigh light scattering (RLS)",
author = "Truong, {Phuoc Long} and Sim, {Sang Jun}",
year = "2015",
doi = "10.1007/978-3-319-11776-8_1",
language = "English",
isbn = "9783319117751",
volume = "46",
pages = "1--6",
booktitle = "IFMBE Proceedings",
publisher = "Springer Verlag",

}

TY - GEN

T1 - Development of individual plasmonic nanosensors for clinical diagnosis

AU - Truong, Phuoc Long

AU - Sim, Sang Jun

PY - 2015

Y1 - 2015

N2 - Accurate detection of panels of protein biomarkers in serum, saliva, or tissue plays an important role in early detection of diseases. Recently, our lab has developed the localized surface plasmon resonance (LSPR)-based immunosensors with highly promising analytical approach for qualification and quantification of biochemical substances in various applications. The LSPR of noble nanoparticles shifts upon refractive index changes of the dielectric environment surrounding the nanoparticles, subsequently causing a peak shift of the LSPR; it is also very sensitive to the binding events near the nanoparticle surface. Therefore, individual nanoparticles are sufficiently sensitive to detect the molecular interactions on the nanoparticle surface induced by biological molecules at ultralow concentrations. Furthermore, LSPR λmax shifts induced by adsorbates on the nanoparticle surface are completely linear with the number of bound molecules. Owing to this reason, each nanoparticle can be used as an independent sensor. By functionalizing the nanoparticle surface with the appropriate receptors, individual nanoparticle sensors can be used as diagnostic tools for a variety of diseases. Herein, we introduce the resonant Rayleigh scattering properties of single Au nanoparticles and the use of single Au nanoparticles as the plasmonic transducers to detect the binding of protein biomarkers to specific receptors conjugated gold nanoparticles. The principle of detection based on the resonant Rayleigh scattering response of single Au nanoparticles and the LSPR λmax shift of resonant Rayleigh scattering spectrum. This approach holds great promise as a simple, label-free, ultrasensitive method for detection of protein biomarkers in clinical diagnostics.

AB - Accurate detection of panels of protein biomarkers in serum, saliva, or tissue plays an important role in early detection of diseases. Recently, our lab has developed the localized surface plasmon resonance (LSPR)-based immunosensors with highly promising analytical approach for qualification and quantification of biochemical substances in various applications. The LSPR of noble nanoparticles shifts upon refractive index changes of the dielectric environment surrounding the nanoparticles, subsequently causing a peak shift of the LSPR; it is also very sensitive to the binding events near the nanoparticle surface. Therefore, individual nanoparticles are sufficiently sensitive to detect the molecular interactions on the nanoparticle surface induced by biological molecules at ultralow concentrations. Furthermore, LSPR λmax shifts induced by adsorbates on the nanoparticle surface are completely linear with the number of bound molecules. Owing to this reason, each nanoparticle can be used as an independent sensor. By functionalizing the nanoparticle surface with the appropriate receptors, individual nanoparticle sensors can be used as diagnostic tools for a variety of diseases. Herein, we introduce the resonant Rayleigh scattering properties of single Au nanoparticles and the use of single Au nanoparticles as the plasmonic transducers to detect the binding of protein biomarkers to specific receptors conjugated gold nanoparticles. The principle of detection based on the resonant Rayleigh scattering response of single Au nanoparticles and the LSPR λmax shift of resonant Rayleigh scattering spectrum. This approach holds great promise as a simple, label-free, ultrasensitive method for detection of protein biomarkers in clinical diagnostics.

KW - Au nanoparticles (AuNPs)

KW - Localized surface plasmon resonance (LSPR)

KW - Plasmonic nanosensors

KW - Rayleigh light scattering (RLS)

UR - http://www.scopus.com/inward/record.url?scp=84928238122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928238122&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-11776-8_1

DO - 10.1007/978-3-319-11776-8_1

M3 - Conference contribution

AN - SCOPUS:84928238122

SN - 9783319117751

VL - 46

SP - 1

EP - 6

BT - IFMBE Proceedings

PB - Springer Verlag

ER -